Literature DB >> 15802683

Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study.

C Morgan1, R Mallett, G Hutchinson, H Bagalkote, K Morgan, P Fearon, P Dazzan, J Boydell, K McKenzie, G Harrison, R Murray, P Jones, T Craig, J Leff.   

Abstract

BACKGROUND: Many studies have found high levels of compulsory admission to psychiatric hospital in the UK among African-Caribbean and Black African patients with a psychotic illness. AIMS: To establish whether African-Caribbean and Black African ethnicity is associated with compulsory admission in an epidemiological sample of patients with a first episode of psychosis drawn from two UK centres.
METHOD: All patients with a first episode of psychosis who made contact with psychiatric services over a 2-year period and were living in defined areas were included in the (AESOP) study. For this analysis we included all White British, other White, African-Caribbean and Black African patients from the AESOP sampling frame. Clinical, socio-demographic and pathways to care data were collected from patients, relatives and case notes.
RESULTS: African-Caribbean patients were significantly more likely to be compulsorily admitted than White British patients, as were Black African patients. African-Caribbean men were the most likely to be compulsorily admitted.
CONCLUSIONS: These findings suggest that factors are operating at or prior to first presentation to increase the risk of compulsory admission among African-Caribbean and Black African patients.

Entities:  

Mesh:

Year:  2005        PMID: 15802683     DOI: 10.1192/bjp.186.4.281

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  46 in total

1.  Ethnic differences in risk of acute compulsory admission in Amsterdam, 1996-2005.

Authors:  Matty A S de Wit; Wilco C Tuinebreijer; Giel H A van Brussel; Jean-Paul Selten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-13       Impact factor: 4.328

2.  First episode psychosis and ethnicity: initial findings from the AESOP study.

Authors:  Craig Morgan; Paola Dazzan; Kevin Morgan; Peter Jones; Glynn Harrison; Julian Leff; Robin Murray; Paul Fearon
Journal:  World Psychiatry       Date:  2006-02       Impact factor: 49.548

Review 3.  Race and mental health: there is more to race than racism.

Authors:  Swaran P Singh; Tom Burns
Journal:  BMJ       Date:  2006-09-23

4.  Editorial is unduly provocative.

Authors:  Cornelius Ani; Obeagaeli Ani
Journal:  BMJ       Date:  2007-04-14

5.  What about stigma, evidence base, and consistency?

Authors:  Trevor Turner; Sue Collinson
Journal:  BMJ       Date:  2007-04-21

6.  Experiences of acute mental health care in an ethnically diverse inner city: qualitative interview study.

Authors:  Scott Weich; Laura Griffith; Martin Commander; Hannah Bradby; S P Sashidharan; Sarah Pemberton; Rubina Jasani; Kamaldeep Singh Bhui
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

7.  Pathways to First-Episode Care for Psychosis in African-, Caribbean-, and European-Origin Groups in Ontario.

Authors:  Kelly K Anderson; Nina Flora; Manuela Ferrari; Andrew Tuck; Suzanne Archie; Sean Kidd; Taryn Tang; Laurence J Kirmayer; Kwame McKenzie
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

8.  Ethnic diversity and pathways to care for a first episode of psychosis in Ontario.

Authors:  S Archie; N Akhtar-Danesh; R Norman; A Malla; P Roy; R B Zipursky
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

9.  Personality disorder and pathways to inpatient psychiatric care.

Authors:  Marianne Hayward; Paul Moran
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-21       Impact factor: 4.328

10.  Examining evidence for neighbourhood variation in the duration of untreated psychosis.

Authors:  J B Kirkbride; D J Lunn; C Morgan; J M Lappin; P Dazzan; K Morgan; P Fearon; R M Murray; P B Jones
Journal:  Health Place       Date:  2009-10-07       Impact factor: 4.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.